Innovaderma Plc

Innovaderma (IDP)

Company name:Innovaderma Plc
EPIC:IDPTrading Currency:GBX
Market Sector:SQS3ISIN:GB00BT9PTW34
Market Segment:SSQ3Share Type:DE
WWW Address: EUR0.10
 Price Price Change [%] Bid Offer Open High Low Volume
 40.00 0.0 [0.00] 39.00 41.00 40.00 40.00 40.00 69,762
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 6.96 17.39 0.14 5.08 - 7.88 - 90.00 - 36.50

Innovaderma Key Figures

(at previous day's close)
Market Cap.6.96m
Shares In Issue17.39m
Prev. Close40.00
PE Ratio7.88 
Dividend Yield-%
EPS - basic5.08p
Dividend PS-p
Dividend Cover- 
Cash Flow PS5.34p
Return On Equity (ROE)7.69%
Operating Margin10.98%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt1.67m
Gross Gearing27.91%
Quick Assets4.64m
Net Working Capital3.22m
Intangibles / Fixed Assets98.94%
Turnover PS58.20p
Pre-Tax Profit PS6.39p
Retained Profit PS3.74p
Cash PS9.25p
Net Cash PS-9.59p
Net Tangible Asset Value PS *18.85p
Net Asset Value PS48.64p
Spread2.00 (4.88%) 

Innovaderma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week40.0040.00
4 weeks42.7539.50
12 weeks51.5039.00
1 year90.0036.50

Share Price Chart (5 years)

Innovaderma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week40.00--40.000.1140.00
4 weeks40.50-0.50-1.2339.500.1040.73
12 weeks47.50-7.50-15.7939.000.1243.38
26 weeks44.50-4.50-10.1136.500.1049.45
1 year40.50-0.50-1.2336.500.0955.83
3 years100.50-60.50-60.2030.000.1384.67
5 years70.00-30.00-42.8630.000.13127.13

Innovaderma Key Management Ratios

Innovaderma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio10.07 
PE Ratio7.88 
Tobin's Q Ratio 0.50 
Tobin's Q Ratio (excl. intangibles)0.90 
Dividend Yield-%
Market-to-Book Ratio0.82 
Price-to-Pre-Tax Profit PS6.26 
Price-to-Retained Profit PS10.69 
Price-to-Cash Flow PS7.49 
Price-to-Sales PS0.69 
Price-to-Net Tangible Asset Value PS2.12 
Price-to-Cash PS4.32 
Net Working Capital PS18.53 
Price Pct to Working Capital PS2.16%
Earnings Yield12.70%
Average PE39.30 
Years in average2 
PE to PE average20.04%

Innovaderma Financial Ratios

(Leverage Ratios)
Debt Ratio-0.00%
Debt-to-Equity Ratio-0.00 
Debt-to-Equity Ratio (excl. Intgbl)-0.00 
Debt-to-Equity Market Value-0.00 
Net Gearing14.20%
Net Gearing (excl. Intangibles)25.43%
Gross Gearing27.91%
Gross Gearing (excl. Intangibles)49.98%
Gearing Under 1 Year27.92%
Gearing Under 1 Year (excl. Intgbl)49.99%
(Liquidity Ratios)
Net Working Capital to Total Assets27.46%
Current Ratio1.98 
Quick Ratio (Acid Test)1.42 
Liquidity Ratio0.49 
Cash & Equiv/Current Assets24.76%
(Solvency Ratios)
Enterprise Value5.35m
CFO/Attributable Profit1.43 
Total Debt/Equity Market Value0.47 
Total Debt/Sales0.32 
Total Debt/Pre-Tax Profit2.95 
Total Debt3.28m
Total Debt/Net Current Assets1.02%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth5.27%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)

Innovaderma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)13.14%
Return On Assets (ROA)4.70%
Net Profit Margin6.43%
Assets Turnover0.73 
Return On Equity (ROE)7.69%
Return On Investment (ROI)6.32%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio6.32%
Net Income Of Revenues6.43%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.98 
Fixed Assets Turnover1.63 
Current Assets Turnover1.32 
Net Working Capital Turnover 
Inventory Turnover3.87 
(Other Operating Ratios)
Total Assets-to-Sales1.37 
Debt Collection Period109.99Days

Innovaderma Dividends

Sorry No Data Available

Innovaderma Fundamentals

 30 Jun 2016 (USD)30 Jun 2017 (USD)30 Jun 2018 (USD)30 Jun 2019 (USD)
pre tax profit0.475.62%1.0311.62%0.676.25%1.4110.98%m
attributable profit0.252.93%0.697.78%0.292.72%0.836.43%m
retained profit0.252.93%0.697.78%0.292.72%0.836.43%m
eps - basic4.00 6.00 - 7.00 
eps - diluted4.00 6.00 - 7.00 
dividends per share- - - - 

Innovaderma Balance Sheet

 30 Jun 2016 (USD)30 Jun 2017 (USD)30 Jun 2018 (USD)30 Jun 2019 (USD)
 30 Jun 2016 (USD)30 Jun 2017 (USD)30 Jun 2018 (USD)30 Jun 2019 (USD)
fixed assets fixed assets0.010.20%0.131.54%0.050.35%0.050.36%m
intangibles intangibles3.4849.49%3.6544.10%5.6944.46%6.5844.15%m
fixed investments fixed investments--%0.010.17%0.030.24%0.020.12%m
current assets - other current assets - other--%0.111.39%--%--%m
stocks stocks1.1115.75%2.2627.33%2.8722.44%2.3615.87%m
debtors debtors2.2231.60%1.9022.96%2.2617.63%3.8425.80%m
cash & securities cash & securities0.212.95%0.212.51%1.9114.88%2.0413.71%m
creditors - short creditors - short2.8039.81%2.9235.34%2.9523.02%4.1627.92%m
creditors - long creditors - long1.0915.44%0.404.90%0.020.13%-0.00-0.00%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves3.1544.75%4.9459.76%9.8476.86%10.7472.09%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Innovaderma Cash Flow Statement

30 Jun 2016 (USD)30 Jun 2017 (USD)30 Jun 2018 (USD)30 Jun 2019 (USD)
Operating CF-0.42-0.610.101.18m
Pre-Financing CF-0.48-0.84-1.960.25m
Retained CF-0.030.371.560.37m

Innovaderma Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210417 12:46:08